🇺🇸 Neorecormon in United States

836 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaemia — 209 reports (25%)
  2. Pyrexia — 96 reports (11.48%)
  3. Thrombocytopenia — 88 reports (10.53%)
  4. General Physical Health Deterioration — 76 reports (9.09%)
  5. Asthenia — 73 reports (8.73%)
  6. Haemoglobin Decreased — 72 reports (8.61%)
  7. Drug Interaction — 57 reports (6.82%)
  8. Pancytopenia — 57 reports (6.82%)
  9. Cardiac Failure — 56 reports (6.7%)
  10. Malaise — 52 reports (6.22%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Neorecormon approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Neorecormon in United States?

Centre Hospitalier Universitaire, Amiens is the originator. The local marketing authorisation holder may differ — check the official source linked above.